Company
Every investor coverage indicates participated in a round World Health Organization raised.
Companies World Health Organization acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming World Health Organization. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Vaxxas reports encouraging interim Phase I results for its needle-free microarray-patch COVID-19 vaccine, with strong antibody responses and no serious adverse events, ahead of planned regulatory applications in Australia and the US.
Vaxxas hires former Pfizer medical executive Dr Rochelle Chaiken as its chief medical officer; the announcement also recounts the biotech's founding financing and later rounds.
Vaxxas has appointed 23-year Pfizer veteran Dr Rochelle Chaiken as chief medical officer; the announcement also recaps the vaccine-patch company's early backing by OneVentures, Brandon Capital and others.
Vaxxas completed a US$23 million (A$34 million) financing led by OneVentures and UniQuest to advance its needle-free vaccine clinical programs, including a COVID-19 candidate, with board members, management and individual investors also participating.
Also OneVentures portfolio·Brandon Capital portfolio·@AuManufacturing·SmartCompany·Techboard·@AuManufacturing
Roundup of Australian manufacturing briefs: Bosch's automation arm partners with Ellume on COVID-19 test production, Tonga receives an Austal-built patrol boat, Micro-X ships Rover X-ray units, and Envirostream wins a government recycling grant.
Vaxxas has received a US$22 million (A$30.6 million) US government BARDA award to advance its needle-free vaccine patch for pandemic use; earlier financing led by OneVentures with Brandon Capital is recalled.
Biotech Vaxxas has won a US government award via BARDA worth US$22 million to advance its needle-free vaccine patch for pandemic influenza; the piece recalls founding backing from OneVentures, Brandon Capital, MRCF and HealthCare Ventures.